When I took antibiotics for a sinus infection, I began feeling weak and feverish, with diarrhea. I went to the ER and learned I had Clostridioides difficile, an infection in the large intestine. The ...

The FDA on Monday granted approval to CutisPharma's drug Firvanq to treat Clostridium difficile-associated diarrhea and Staphylococcus aureus-associated intestinal inflammation (enterocolitis). Here ...

You pay a visit to the dentist, he gives you some antibiotics for that toothache, and shortly afterward you develop diarrhea. Doesn’t sound right, does it? But happens more often than you would think.

Clostridium difficile is the most common cause of nosocomial diarrhea in acute-care settings. Until now, the two available therapies for C. difficile-associated diarrhea (CDAD), vancomycin and ...

Forbes contributors publish independent expert analyses and insights. Keep in mind that this was a very small trial in Norway. Scientists write research letters to medical journals when they don't ...

Clostridium difficile, a bacterium that causes swelling of the colon and potentially deadly bouts of diarrhea, infects almost half a million people each year and contributes to the deaths of 29,000, ...

C. diff is a horrible disease that can cause significant morbidity. It can and often does recur and kills around 30,000 Americans every year. We have made progress in prevention and treatment, but ...

LAS VEGAS — Potentially deadly antibiotic-associated Clostridium difficile-associated diarrhea (CDAD) affects 3 million Americans each year and is increasingly difficult to treat. Clinicians may want ...

The risk of getting a deadly, treatment-resistant infection in a hospital or nursing home is dropping for the first time in decades, thanks to new guidelines on antibiotic use and stricter cleaning ...

It seemed like such a great idea. But at the end of the day, as they say, those dogs didn’t hunt. Or at least not well enough. New research from Toronto throws into question the notion that canines ...

The FDA on Monday granted approval to CutisPharma’s drug Firvanq to treat Clostridium difficile-associated diarrhea and Staphylococcus aureus-associated intestinal inflammation (enterocolitis). Here ...